Spatial Gating Probe for Pancreatic Cyst Diagnosis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for pancreatic cysts lack accuracy in distinguishing between precancerous and benign cysts, leading to unnecessary surgeries and missed malignant cases, due to the limitations of conventional imaging tools and cytology analysis.

Innovation Solution

A spatial gating probe using light scattering spectroscopy is integrated into an endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) needle to differentiate between benign and malignant pancreatic cysts by isolating the epithelial nuclear scattering spectrum, allowing for precise identification of cysts that require surgical intervention.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional imaging tools and cytology analysis are used to diagnose pancreatic cysts, then the diagnostic process is simple and widely available, but the accuracy in distinguishing precancerous from benign cysts is insufficient

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddiagnostic system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines light scattering spectroscopy with EUS-FNA procedures, merging optical diagnostic capabilities with existing ultrasound-guided needle aspiration technology. This integration allows simultaneous acquisition of morphological (ultrasound) and molecular/optical (light scattering) data, improving diagnostic accuracy without requiring completely separate diagnostic systems

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces light scattering spectroscopy as an intermediary diagnostic modality between conventional imaging and histopathological analysis. The optical spectra serve as a mediator that provides molecular-level information about cyst epithelium, bridging the gap between non-invasive imaging and invasive biopsy analysis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If light scattering spectroscopy with spatial gating is implemented, then diagnostic accuracy is improved, but the device complexity and procedural complexity increase

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidprocedural ease
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent designs the optical probe to perform multiple functions: it delivers light for spectroscopy, collects scattered light for detection, and can be integrated with the existing EUS-FNA needle system. This multi-functionality reduces the need for separate specialized equipment and simplifies the overall procedural workflow despite the advanced diagnostic capabilities

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The spatial gating technique automatically isolates epithelial nuclear scattering signals from the complex backscattered light based on their distinct spectral characteristics. The system self-calibrates by identifying the unique optical signatures of nuclear scattering without requiring manual intervention or complex post-processing, making the advanced technique easier to operate

Inventive Principle:
Principle #25Self-service

3Reliability

If conventional diagnostic methods are used, then the procedure is quick and simple, but malignant cases may be missed leading to poor patient outcomes

Engineering Contradiction:
Improvedetection reliabilityVSAvoiddiagnostic time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent performs light scattering spectroscopy during the EUS-FNA procedure itself, before the cyst fluid is sent for conventional cytology analysis. This preliminary optical assessment provides immediate information about malignant potential, allowing clinicians to make real-time decisions about further management without waiting for slower conventional diagnostic results

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system provides immediate feedback through optical spectra analysis during the FNA procedure. The real-time detection of malignant optical signatures allows clinicians to adjust their diagnostic approach instantly, improving detection reliability without significant time loss by providing results during rather than after the procedure

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The technique provides accurate classification of pancreatic cysts, reducing unnecessary surgeries and identifying malignant cases that would otherwise be missed, with the potential to improve patient outcomes by enhancing diagnostic accuracy during routine EUS-FNA procedures.

Implementation Method 1

light scattering spectroscopy

Methodology Applied
Scientific EffectLight scattering: Scattering

Implementation Method 2

receive light reflected from the pancreatic cyst

Methodology Applied
Scientific EffectReflection: Reflection

Data Source

PatentUS11931163B2Method and apparatus to determine the malignant potential of pancreatic cysts using light scattering spectroscopy
Publication Date: 2024.03.19 BETH ISRAEL DEACONESS MEDICAL CENT INC
  • US11931163B2 patent drawing
  • US11931163B2 patent drawing
  • US11931163B2 patent drawing

AI summary

Described herein are embodiments of an approach to diagnosing pancreatic cystic lesions using light scattering spectroscopy. In some embodiments, the approach includes an apparatus including a spatial gating probe to isolate light reflected by the epithelial tissue of the internal cyst surface using spatial gating. In some further embodiments, the apparatus includes a scanning fiber probe that is capable of rotational and linear motion in order to scan the entire internal surface of the cyst. Use of such an approach may be advantageous to improve the accuracy of diagnosing pancreatic cystic lesions as cancerous, precancerous, or benign.